SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-099431
Filing Date
2023-12-29
Accepted
2023-12-29 07:30:32
Documents
12
Period of Report
2023-12-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190867-8k_virpaxpharm.htm   iXBRL 8-K 33916
  Complete submission text file 0001213900-23-099431.txt   209297

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vrpx-20231228.xsd EX-101.SCH 3027
3 XBRL LABEL FILE vrpx-20231228_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE vrpx-20231228_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT ea190867-8k_virpaxpharm_htm.xml XML 3420
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 231524294
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)